Your browser doesn't support javascript.
loading
Effectiveness of Fingolimod versus Natalizumab as Second-Line Therapy for Relapsing-Remitting Multiple Sclerosis in Spain: Second-Line GATE Study.
Meca-Lallana, José; Ayuso, Teresa; Martínez-Yelamos, Sergio; Durán, Carmen; Contreras Martín, Yessica; Herrera Navarro, Nicolás; Pérez Sempere, Angel; Álvarez-Cermeño, Jose C; Millán Pascual, Jorge; Meca-Lallana, Virginia; Romero Sevilla, Raúl; Ricart, Javier.
Affiliation
  • Meca-Lallana J; Unidad de Esclerosis Múltiple, Servicio de Neurología, Hospital Clínico Universitario "Virgen de la Arrixaca" (IMIB-ARRIXACA), Murcia, Spain, pmecal@gmail.com.
  • Ayuso T; Cátedra de Neuroinmunología Clínica y Esclerosis Múltiple, UCAM, Universidad Católica San Antonio, Murcia, Spain, pmecal@gmail.com.
  • Martínez-Yelamos S; Hospital de Navarra, Pamplona, Spain.
  • Durán C; Hospital de Bellvitge, Hospitalet de Llobregat, Spain.
  • Contreras Martín Y; Hospital Universitario Infanta Cristina, Badajoz, Spain.
  • Herrera Navarro N; Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Spain.
  • Pérez Sempere A; Hospital de Burgos, Burgos, Spain.
  • Álvarez-Cermeño JC; Hospital General de Alicante, Alicante, Spain.
  • Millán Pascual J; Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain.
  • Meca-Lallana V; Complejo Hospitalario La Mancha Centro, Alcázar de San Juan, Spain.
  • Romero Sevilla R; Unidad de Enfermedades Desmielinizantes, Hospital Universitario de la Princesa, Madrid, Spain.
  • Ricart J; Novartis Farmacéutica S.A., Barcelona, Spain.
Eur Neurol ; 83(1): 25-33, 2020.
Article in En | MEDLINE | ID: mdl-32187609
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Multiple Sclerosis, Relapsing-Remitting / Fingolimod Hydrochloride / Natalizumab / Immunosuppressive Agents Type of study: Observational_studies Limits: Adult / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Eur Neurol Year: 2020 Document type: Article Country of publication: Switzerland
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Multiple Sclerosis, Relapsing-Remitting / Fingolimod Hydrochloride / Natalizumab / Immunosuppressive Agents Type of study: Observational_studies Limits: Adult / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Eur Neurol Year: 2020 Document type: Article Country of publication: Switzerland